Veeva Vault Infographic v23 · CIO, inVentiv Health **As of January 31, 2016 **As of July 31, 2016...
1
The Changing Landscape in Life Sciences There is more content and complexity to manage. Challenges in Content Management Regulations, legacy technology, and multiple systems are creating difficulties. Change is Underway The industry is investing in transformational change. Unified Content Management Companies are improving collaboration, lowering costs, and reducing risk. Leading Transformation in Content Management Veeva innovation is driving changes in Life Sciences. Delivering Customer Success Helping customers streamline their global business processes. Visit veeva.com/vault to learn more 55% * Reduction in time spent in MLR/PRC meetings Fewer systems for a single source of truth Improved compliance for critical business processes Top 50 pharma customers Total customers Planning a change in submissions document management Veeva Vault Total Addressable Market 75% $4 Billion * Inspections delayed due to inaccessible or incomplete TMFs Federal, state, and industry laws, standards, and regulations Leaders burdened by multiple systems 2011 applications releases per year 2013 2015 2012 2014 2016 True multitenant cloud solution for single source of truth Real-time reporting and dashboards Unified content and data management on one platform Crosslinks for full enterprise view of content across functions Unified cloud suites for clinical, regulatory, and quality First suite of applications to unify clinical operations First applications for clinical data management on single cloud platform 12 SOURCES 2011 AIM ECM Survey; Forbes article: 2015 Drug Approvals Hit 66 Year High; clinicaltrials.gov and fda.gov; Visiongain, “Pharmaceutical Contract Manufacturing World Market To Reach $79.24bn in 2019,” Press Release, February 10, 2015; MHRA GCP Symposium, September 2016; Cadence Group 2011; Veeva 2015 Commercial Content Management Survey; Gens & Associates, Pursuing World Class Regulatory Management (RIM): Strategy, Measure and Priorities, 2016 (results based on a survey of 54 companies); Veeva Vault PromoMats Datasheet; Deloitte 2016 Global Life Sciences Outlook; *Veeva internal research and customer data 34 ** 3x 14,000+ 57% * Reduction in review cycle time 278 ** The Transformation of Content Management in Life Sciences 89% * 31% With Vault in place to standardize document processes, we will have greater visibility and efficiency globally. inVentiv identified Veeva as a best-of-breed platform that can maximize efficiencies and accelerate the delivery of much needed drugs to patients. Malika Mir, Chief Information Officer, Ipsen Rachel Stahler, CIO, inVentiv Health **As of January 31, 2016 **As of July 31, 2016 51 New Drug Approvals A 66-year high in 2015 70K 300M 200K Managing content has become more complex. The amount of information to bring drugs to market rises each year. New Investigator Sites Pages of Clinical Information FDA Submissions Outsourcing continues to rapidly expand. Expected global CMO market in 2019, increasing at an average annual rate of 7.5% $79.24B 30% * Reduction in lot release time
Transcript of Veeva Vault Infographic v23 · CIO, inVentiv Health **As of January 31, 2016 **As of July 31, 2016...
The Changing Landscape in Life SciencesThere is more content and complexity to manage.
Challenges in Content ManagementRegulations, legacy technology, and multiple systems are creating di�iculties.
Change is UnderwayThe industry is investing in transformational change.
Unified Content ManagementCompanies are improving collaboration, lowering costs, and reducing risk.
Leading Transformationin Content ManagementVeeva innovation is driving changes in Life Sciences.
Delivering Customer SuccessHelping customers streamline their global business processes.
Visit veeva.com/vault to learn more
55%*
Reduction in time spent in MLR/PRC meetings
Fewer systems for a single source of truth
Improved compliance forcritical business processes
Top 50 pharma customers Total customers
Planning a change in submissions document management
Veeva Vault Total Addressable Market
75%
$4 Billion*
Inspections delayed due to inaccessible or incomplete TMFs
Federal, state, and industry laws, standards, and regulations
Leaders burdened by multiple systems
2011
applicationsreleases per year
2013 2015
2012 2014 2016
True multitenant cloud solution for single source of truth
Real-time reporting and dashboards
Unified content and data management on one platform
Crosslinks for full enterprise view of content across functions
Unified cloud suites for clinical, regulatory, and quality
First suite of applications to unify clinical operations
First applications for clinical data management on single cloud platform
12
SOURCES2011 AIM ECM Survey; Forbes article: 2015 Drug Approvals Hit 66 Year High; clinicaltrials.gov and fda.gov; Visiongain, “Pharmaceutical Contract Manufacturing World Market To Reach $79.24bn in 2019,” Press Release, February 10, 2015; MHRA GCP Symposium, September 2016; Cadence Group 2011; Veeva 2015 Commercial Content Management Survey; Gens & Associates, Pursuing World Class Regulatory Management (RIM): Strategy, Measure and Priorities, 2016 (results based on a survey of 54 companies); Veeva Vault PromoMats Datasheet; Deloitte 2016 Global Life Sciences Outlook; *Veeva internal research and customer data
34**
3x
14,000+
57%*
Reduction in review cycle time
278**
The Transformationof Content Managementin Life Sciences
89%*31%
With Vault in place to standardize document processes, we will have greater visibility and e�iciency globally.
inVentiv identified Veeva as a best-of-breed platform that can maximize e�iciencies and accelerate the delivery of much needed drugs to patients.
Malika Mir, Chief Information O�icer, Ipsen
Rachel Stahler, CIO, inVentiv Health
**As of January 31, 2016 **As of July 31, 2016
51New Drug Approvals
A 66-year high in 2015
70K 300M 200K
Managing content has become more complex.
The amount of information to bring drugs to market rises each year.
New Investigator Sites
Pages of Clinical Information
FDA Submissions
Outsourcing continues to rapidly expand.
Expected global CMO market in 2019, increasing at an average annual rate of 7.5% $79.24B
30%*
Reduction in lot release time
